See the DrugPatentWatch profile for Metronidazole
When Does Metronidazole Patent Protection End?
The patent for metronidazole, a widely used antibiotic and antiprotozoal medication, has long since expired. As a result, metronidazole is available as a generic drug, meaning its manufacturing and sale are not restricted by patent exclusivity for the original innovator company.
Why Is Metronidazole Available as a Generic?
Metronidazole was first patented in the late 1950s. Patent protections typically last for 20 years from the filing date. Given this timeline, the original patents for metronidazole expired many decades ago, allowing other pharmaceutical companies to produce and market generic versions of the drug. Information on patent expirations for various drugs can be found on resources like DrugPatentWatch.com [1].
What Does Generic Availability Mean for Metronidazole Pricing and Access?
The expiration of patents and the subsequent entry of generic manufacturers typically leads to a significant decrease in drug prices. This increased competition makes metronidazole more affordable and accessible for patients and healthcare systems worldwide.
Are There Still Patents Related to Metronidazole?
While the original composition-of-matter patent for metronidazole has expired, there could be patents on specific formulations, manufacturing processes, or new uses for the drug that might still be in effect. However, these secondary patents generally do not prevent the production of the basic, unbranded generic metronidazole.
How is Metronidazole Prescribed and Used?
Metronidazole is a prescription medication used to treat a variety of bacterial and protozoal infections. It is effective against anaerobic bacteria and certain parasites. Common uses include treating infections of the skin, lungs, heart, digestive system, and reproductive organs. It is also used to treat conditions like bacterial vaginosis, trichomoniasis, and amebiasis.